CytRx Corp
CYTR
CYTR was delisted on the 3rd of June, 2019.
47 hedge funds and large institutions have $5.08M invested in CytRx Corp in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 11 closing their positions.
527% more call options, than puts
Call options by funds: $188K | Put options by funds: $30K
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
13% less funds holding
Funds holding: 54 → 47 (-7)
38% less capital invested
Capital invested by funds: $8.14M → $5.08M (-$3.07M)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$1.09M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$287K |
| 3 |
BlackRock
New York
|
+$160K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$88.6K |
| 5 |
VF
Virtu Financial
New York
|
+$83.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Element Capital Management
New York
|
-$380K |
| 2 |
Goldman Sachs
New York
|
-$376K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$271K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$235K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$232K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | -$38.3K | -11,322 | -100% |
|
52
Squarepoint
New York
| – | -$33K | -8,839 | Closed |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| – | -$9K | -2,504 | Closed |
|
54
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2K | -474 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | +$226 | +67 | New |
|
CYTR Hedge Fund Activity: Q3 2017 in Review
47 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q3 2017, worth a combined $5.08M — down 38% from $8.14M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CYTR and 5 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 12 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $1.09M. The largest seller was Element Capital Management, exiting entirely with an estimated $380K sold.
- 47 institutional investors held CytRx Corp (CYTR) as of Q3 2017, down from 54 in Q2 2017.
- Funds reported $5.08M of CytRx Corp stock for Q3 2017, down 38% quarter-over-quarter.
- 5 funds opened new CytRx Corp positions in Q3 2017 and 11 closed out, a net change of -6 holders.
- The largest CytRx Corp buyer in Q3 2017 was D.E. Shaw & Co, an estimated $1.09M added.
- The largest CytRx Corp seller in Q3 2017 was Element Capital Management, an estimated $380K sold.
Based on aggregated 13F filings for Q3 2017.